Education Initiatives
- Home
- Young Community
- Education Initiatives
- Research Initiatives
- Education Initiatives
- Interventional Young Community
- Heart Failure Young Community
- Young Community Members
- Resource Library
- Discussion forum
- Applying for Membership
Education Initiatives
・APSC General Cardiology review
・APSC Emerging leaders course
・Dedicated sessions at regional and international conferences
・Education research
・APSC Journal Club series
- Landmark Trials of SGLT2 Inhibitors in HFrEF
- ANTITHROMBOTIC REGIME IN AF PATIENTS UNDERGOING PCI
- Role of SGLT2 in HFpEF and its impact on renal outcomes
- Role of P2Y12 inhibitor therapy in ACS and after PCI: Twilight and ISAR REACT
- Cardiovascular, Renal and Metabolic Benefits of SGLT2i Type 2 Diabetes and Heart Failu
- TAVI for severe aortic stenosis: Insights from latest trials
- Pharmacological therapies in management of HFrEF
- Revascularisation in Ischemic Cardiomyopathy